Full title: CIGNA CORPORATION, Plaintiff, v. AMY BRICKER, et al. Defendants.
Court: United States District Court, Eastern District of Missouri
Date published: Mar 17, 2023
Facts
This matter is before the Court on Plaintiff Cigna Corporation’s Motion for Protective Order or in the Alternative to Quash the Deposition Notice of David Cordani, the Chief Executive Officer (“CEO”) of Cigna Corporation (“Cigna”). Defendants Amy Bricker and CVS Pharmacy, Inc. (“CVS Pharmacy”) opposed the motion and filed a joint response memorandum in opposition, to which Cigna filed a reply. The motion is fully briefed and ripe for review.
Federal Rule of Civil Procedure 26, which governs the scope of discovery in federal matters, provides the following:
Parties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit. Information within this scope of discovery need not be admissible in evidence to be discoverable.
Issue
Decision
Accordingly, IT IS HEREBY ORDERED that Plaintiff Cigna Corporation’s Motion for Protective Order or Alternative to Quash the Deposition Notice of David Cordani, the Chief Executive Officer of Cigna Corporation, is DENIED. [ECF No. 82]
Also, Read